In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study.
about
Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma.The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells.Perspectives of CD44 targeting therapies.Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers.CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches.Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy.
P2860
In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo characterization of th ...... rcinoma: a dual-isotope study.
@en
In vivo characterization of th ...... rcinoma: a dual-isotope study.
@nl
type
label
In vivo characterization of th ...... rcinoma: a dual-isotope study.
@en
In vivo characterization of th ...... rcinoma: a dual-isotope study.
@nl
prefLabel
In vivo characterization of th ...... rcinoma: a dual-isotope study.
@en
In vivo characterization of th ...... rcinoma: a dual-isotope study.
@nl
P2093
P2860
P356
P1433
P1476
In vivo characterization of th ...... arcinoma: a dual-isotope study
@en
P2093
Anna-Karin Haylock
Johan Nilvebrant
Karl Sandström
Marika Nestor
P2860
P2888
P356
10.1186/2191-219X-4-11
P577
2014-03-06T00:00:00Z
P6179
1029911479